The diagnosis and medical management of advanced neuroendocrine tumors.
The DOI matches its Crossref record; 657 of the 670 references it cites were found in a registry or an index.
Abstract
Neuroendocrine tumors (NETs) constitute a heterogeneous group of neoplasms that originate from endocrine glands such as the pituitary, the parathyroids, and the (neuroendocrine) adrenal, as well as endocrine islets within glandular tissue (thyroid or pancreatic) and cells dispersed between exocrine cells, such as endocrine cells of the digestive (gastroenteropancreatic) and respiratory tracts. Conventionally, NETs may present with a wide variety of functional or nonfunctional endocrine syndromes and may be familial and have other associated tumors. Assessment of specific or general tumor markers offers high sensitivity in establishing the diagnosis and can also have prognostic significance. Imaging modalities include endoscopic ultrasonography, computed tomography and magnetic resonance imaging, and particularly, scintigraphy with somatostatin analogs and metaiodobenzylguanidine. Successful treatment of disseminated NETs requires a multimodal approach; radical tumor surgery may be curative but is rarely possible. Well-differentiated and slow-growing gastroenteropancreatic tumors should be treated with somatostatin analogs or alpha-interferon, with chemotherapy being reserved for poorly differentiated and progressive tumors. Therapy with radionuclides may be used for tumors exhibiting uptake to a diagnostic scan, either after surgery to eradicate microscopic residual disease or later if conventional treatment or biotherapy fails. Maintenance of the quality of life should be a priority, particularly because patients with disseminated disease may experience prolonged survival.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“With the combination of noninvasive and selected invasive modalities (particularly endoscopic ultrasound), most insulinomas are localized preoperatively (72, 78).”
From Evaluation and Management of Adult Hypoglycemic Disorders: An Endocrine Society Clinical Practice Guideline (2009) · cites this paper as [72]
In the citing paper
“Although the results with a given method reflect the experience and expertise with that method at a given center, computed tomography, MRI, and transabdominal ultrasonography detect most insulinomas (71-73).”
From Evaluation and Management of Adult Hypoglycemic Disorders: An Endocrine Society Clinical Practice Guideline (2009) · cites this paper as [72]
Citations
Cites
Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death
Hockenbery, D., Nuñez, G., Milliman, C., Schreiber, R. D., & Korsmeyer, S. J. (1990) · Nature · doi:10.1038/348334a0 · Cited by 3,720
Induction of apoptosis in fibroblasts by c-myc protein
Evan, G. I., Wyllie, A. H., Gilbert, C. S., Littlewood, T. D., Land, H., Brooks, M., Waters, C. M., Penn, L. Z., & Hancock, D. C. (1992) · Cell · doi:10.1016/0092-8674(92)90123-t · Cited by 2,935
A 5‐decade analysis of 13,715 carcinoid tumors
Modlin, I. M., Lye, K. D., & Kidd, M. (2003) · Cancer · doi:10.1002/cncr.11105 · Cited by 2,734
CONSENSUS: Guidelines for Diagnosis and Therapy of MEN Type 1 and Type 2
Brandi, M. L. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.12.5658 · Cited by 2,031
Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A
Mulligan, L. M., Kwok, J. B. J., Healey, C. S., Elsdon, M. J., Eng, C., Gardner, E., Love, D. R., Mole, S. E., Moore, J. K., Papi, L., et al. (1993) · Nature · doi:10.1038/363458a0 · Cited by 1,966
Mutations in SDHD , a Mitochondrial Complex II Gene, in Hereditary Paraganglioma
Baysal, B. E., Ferrell, R. E., Willett-Brozick, J. E., Lawrence, E. C., Myssiorek, D., Bosch, A., Mey, A. V. D., Taschner, P. E. M., Rubinstein, W. S., Myers, E. N., et al. (2000) · Science · doi:10.1126/science.287.5454.848 · Cited by 1,638
Krenning, E. P., Kwekkeboom, D. J., Bakker, W. H., Breeman, W. A. P., Kooij, P. P. M., Oei, H. Y., van Hagen, M., Postema, P. T. E., de Jong, M., Reubi, J. C., et al. (1993) · European Journal of Nuclear Medicine · doi:10.1007/bf00181765 · Cited by 1,564
Gutmann, D. H. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03550010065042 · Cited by 1,359
An analysis of 8305 cases of carcinoid tumors
Modlin, I. M., & Sandor, A. (2000) · Cancer · doi:10.1002/(sici)1097-0142(19970215)79:4<813::aid-cncr19>3.0.co;2-2 · Cited by 1,200
The Complex of Myxomas, Spotty Pigmentation, and Endocrine Overactivity
CARNEY, J. A., GORDON, H., CARPENTER, P. C., SHENOY, B. V., & W. GO, V. L. (1985) · Medicine · doi:10.1097/00005792-198507000-00007 · Cited by 1,114
Research works printed but not linked: 3
- Krenning, 1994, Essentials of peptide receptor scintigraphy with emphasis on the somatostatin analog octreotide., Semin Oncol, 21, 6
- Janson, 2000, Nuclear localization of 111In after intravenous injection of [111In-DTPA-D-Phe1]-octreotide in patients with neuroendocrine tumors., J Nucl Med, 41, 1514
- Bartsch, 1990, Treatment of metastatic carcinoid tumors by recombinant human interferon-α. Results from a phase II study., J Cancer Res Clin Oncol, 116, 305
Cited by
Items 501–600 of 679
Ali, Z. E., Iwanik, K., Sowiński, J., Swora-Cwynar, E., & Grzymislawski, M. B. (2009) · PubMed · Cited by 1
Amair-Pinedo, F., Matos, I. G., Saurí, T., Hernando, J., & Capdevila, J. (2017) · Targeted Oncology · doi:10.1007/s11523-017-0532-3 · Cited by 1
“In advanced disease, the aim of medical treatment is to control disease progression and hormonerelated symptoms [82].”
BackgroundPRRT with Radiolabeled Peptides: Indications, Procedures, and Results
Seregni, E. C., & Lorenzoni, A. (2018) · Springer eBooks · doi:10.1007/978-3-319-63067-0_22 · Cited by 1
Veselova, I. A., Makedonskaya, M. I., Eremina, O. E., & Shekhovtsova, T. N. (2021) · Springer eBooks · doi:10.1007/978-3-030-55490-3_8 · Cited by 1
Management of neuroendocrine tumours
Lansdown, A., & Rees, A. (2015) · Cambridge University Press eBooks · doi:10.1017/cbo9781107280250.041 · Cited by 1
Özkul, N., & Kann, P. H. (2021) · Ultrasound International Open · doi:10.1055/a-1626-1678 · Cited by 1
“Thus far, standard imaging modalities include computed tomography (CT), magnetic resonance imaging (MRI), scintigraphy with somatostatin analogs, and metaiodobenzylguanidine (MIBG), often used in combination [2, 3, 6, 7].”
BackgroundMethodPancreatic Neuroendocrine Tumors
Muniraj, T., & Aslanian, H. R. (2021) · Springer eBooks · doi:10.1007/978-3-030-30192-7_81 · Cited by 1
Pancreatic Neuroendocrine Tumors
Muniraj, T., & Aslanian, H. R. (2020) · Springer eBooks · doi:10.1007/978-3-319-90761-1_81-1 · Cited by 1
Gastric Tumors (Other than Adenocarcinoma)
Pitchumoni, C. S., Chaubal, A., & Desai, G. (2021) · Springer eBooks · doi:10.1007/978-3-030-30192-7_117 · Cited by 2
dos Anjos, C. S., Rosa, V. D. L., Godoy, A. C. C., Thomé, J. L. C., Rapatoni, L., Saggioro, F. P., Neder, L., de Oliveira, R. J., de Oliveira, H. F., & Peria, F. M. (2015) · Clinical Case Reports and Reviews · doi:10.15761/ccrr.1000138 · Cited by 1
Tadman, M., Davies, P., Whyand, T., & Martin, L. (2019) · Springer eBooks · doi:10.1007/978-3-319-99817-6_65 · Cited by 1
Medical and Nucleotide Treatment of Neuroendocrine Tumors of the Pancreas
Tsoli, M., & Kaltsas, G. (2023) · Wiley eBooks · doi:10.1002/9781119876007.ch106 · Cited by 1
Self-citationFunctional Retrocaval paraganglioma: Case Report and Review of Literature
Pal, D. K., Sarkar, D., & Tandon, M. (2023) · Journal of Pediatric and Adolescent Surgery · doi:10.46831/jpas.v2i2.147 · Cited by 1
Neuroendocrine Neoplasms of the Digestive System
Esposito, I., Klöppel, G., Esposito, I., Kasajima, A., Rosa, S. L., Dizdar, L., Knoefe, W. T., Schott, M., Dromain, C., Villard, N., et al. (2024) · Wiley eBooks · doi:10.1002/9781119756422.ch24 · Cited by 2
Paraneoplastic neurologic manifestations of neuroendocrine tumors
Zoccarato, M., & Grisold, W. (2024) · Handbook of clinical neurology · doi:10.1016/b978-0-12-823912-4.00023-2 · Cited by 1
Bronchospasm Complicating A Small Intestine Neuroendocrine Tumor Resection: A Case Report
Amine, B. (2024) · doi:10.58372/2835-6276.1144 · Cited by 1
Kolyago, O. O., Munirova, A. A., Ivanov, S. V., & Stilidi, I. S. (2024) · Almanac of Clinical Medicine · doi:10.18786/2072-0505-2024-52-015 · Cited by 1
Low-grade duodenal neuroendocrine tumor in a 72-year-old man: A case report
Al-Jawad, M., Hashemagha, D., Salem, A., Seijari, N., Hussein, S., & Niazi, A. (2025) · International Journal of Surgery Case Reports · doi:10.1016/j.ijscr.2025.111232 · Cited by 1
Pancreatic Incidentalomas: Review and Current Management Recommendations
Sureka, B., & Varshney, V. K. (2019) · Annals of the National Academy of Medical Sciences (India) · doi:10.1055/s-0039-1694074 · Cited by 1
Nichtoperative Therapiemöglichkeiten gastroenteropankreatischer neuroendokriner Tumoren
Busse, F. P., Mössner, J., Stümvoll, M., Kluge, R., & Schoppmeyer, K. (2007) · Visceral Medicine · doi:10.1159/000101533 · Cited by 1
Sharing management of neuroendocrine tumours
Bouvier, C., & Hayman, A. (2005) · Practice Nursing · doi:10.12968/pnur.2005.16.1.17347 · Cited by 1
Mínimas alterações hormonais em paciente com grande feocromocitoma
Lima, J. G., Bandeira, F. A. F., Bandeira, C., de Paula, M., Nóbrega, M. L. C., Costa, S. O. E., & Nóbrega, L. H. C. (2006) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302006000100020 · Cited by 2
Papadogias, D., Makras, P., Griniatsos, I., Kaltsas, G., & Grossman, A. B. (2006) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/01.med.0000235326.31541.a5 · Cited by 1
Self-citationTsoli, M., & Kaltsas, G. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.65346-1 · Cited by 1
Self-citationQuels marqueurs circulants pour quels cancers?
You, B. (2007) · Bio Tribune Magazine · doi:10.1007/s11834-007-0019-0
A New nutritional Approach for promoting Gut Health and Animal Performance
Ulgheri, C. (2010) · DocTA - Doctoral Theses Archive · doi:10.83049/unicatt/publicatt/10280_770
Kalhan, A., & Rees, A. (2008) · Cambridge University Press eBooks · doi:10.1017/cbo9780511545375.037
Seidenberger, K. (2007) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2007.tde-11122007-131612
Tohmola, N. (2015) · Työväentutkimus Vuosikirja
Zentrale Rolle des Hausarztes bei der Diabetesprävention
Sarnighausen, H. (2010) · Journal für Kardiologie (Krause & Pachernegg GmbH)
Classification of Endocrine Tumors of the Pancreas
Mukherjee, J. J., & Lee, K. (2015) · Wiley eBooks · doi:10.1002/9781118307816.ch40
The current status in diagnosis of gastrointestinal carcinoid tumors
Dimitroulopoulos, D., Fotopoulou, A., Xinopoulos, D., Tsamakidis, K., & Paraskevas, E. (2008) · Annals of Gastroenterology
Particularités des tumeurs endocrines avec sécrétion ectopique d’ACTH
Young, J., & Tabarin, A. (2008) · Springer eBooks · doi:10.1007/978-2-287-35574-5_7 · Cited by 1
Particularités de l’insulinome
Chanson, P., & Kamenický, P. (2008) · Springer eBooks · doi:10.1007/978-2-287-35574-5_5 · Cited by 1
Radiothérapie vectorisée des tumeurs endocrines digestives
Borson‐Chazot, F., & Corone, C. (2007) · Hépato-Gastro & Oncologie Digestive · doi:10.1684/hpg.2007.0057
“La propriété des tumeurs endocrines d’exprimer des récepteurs pour la somatostatine est utilisée depuis une quinzaine d’années pour leur diagnostic scintigraphique et leur traitement symptomatique [3-5].”
BackgroundLigand-Directed AAVP to Deliver a Therapeutic Transgene to Neuroendocrine Tumors of the Pancreas
Smith, T. L. (2013) · Digital Commons-TMC (Texas Medical Center)
Sandoval, M. A., Lo, T. E., Berberabe, A. E., Lusong, M. A. D., & Co, J. M. I. (2015) · Journal of the ASEAN Federation of Endocrine Societies · doi:10.15605/jafes.030.02.05
Metastatic Carcinoid Tumor Presenting As Right Sided Heart Failure
Martínez‐Quintana, E., Avila-Gonzalez, M. D. M., Suárez-Castellano, L., & Rodríguez‐González, F. (2013) · Intern J Endocrinol Metab · doi:10.5812/ijem.6927
Tumores neuroendocrinos de origen incierto: a propósito de 2 casos clínicos
Vargas, M. F., Serrano, B. L., Fraile, I. P., & Durán, M. C. (2009) · Medicina de Familia SEMERGEN · doi:10.1016/s1138-3593(09)70928-1
Non oncologic elevated levels of chromogranin A in a symptomatic patient without a carcinoid tumor
Duque, J. C., Pineda, L. F., & Lopez, T. (2013) · Endocrinology Studies · doi:10.4081/es.2013.e7
Neuroendocrine tumours of the chest area
Jabłoński, S., & Brocki, M. (2010) · Polish Journal of Surgery · doi:10.2478/v10035-010-0016-y
Carcinoid syndrome in neuroendocrine tumors - not easy to recognize
Bjelović, M. (2013) · Acta chirurgica iugoslavica · doi:10.2298/aci1303013b
Lawrence, B. J., Anderson, Schimmack, Findlay, Kidd, & Modlin (2012) · Gastrointestinal Cancer Targets and Therapy · doi:10.2147/gictt.s21939
Nuclear medicine in the treatment of neuroendocrine tumours—problems and perspectives
Grzela, T., Białoszewska, A., & Brawura-Biskupski-Samaha, R. (2006) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-006-0300-6
“On the other hand, some mechanisms responsible for active radiotracer elimination, including multidrug resistance, or intrinsic mechanisms protecting against radiation-induced apoptosis could be involved in (131)I-MIBG resistance [2, 15, 16].”
BackgroundInfluentialPerformance Evaluation of the Elecsys Neuron-Specific Enolase Assay
Kim, S., Jeong, T., Lee, W., Chun, S., & Min, W. (2015) · Laboratory Medicine Online · doi:10.3343/lmo.2015.5.2.63
“신경내분비세포란 신경자극을 받아 호르몬을 분비 하는 세포로서 뇌하수체의 코르티코트로프(corticotrophs), 부갑 상선의 C 세포, 부신수질의 크롬친화세포, 췌장의 베타세포, 폐의 신경상피세포 등이 대표적이다[4, 6].”
Villabona, C. M., Casanovas, O., & Salazar, R. (2007) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(07)71512-7
A Case of ACTH-producing Pancreatic Neuroendocrine Tumor Presenting with Cushing Syndrome
Yeum, S.-C., Won, J.-H., Byun, D. W., Jeen, Y. M., & Hyeong-Kyu, P. (2012) · Soonchunhyang Medical Science · doi:10.15746/sms.12.035
“ACTHoma는 다른 신경내분비종양에 비해 전이가 흔하며 95% 이상에서 전이를 보이는 악성도가 높은 암으로 환자의 60%가 2년 내에 사망하고 5년 생존율이 16%로 예후가 매우 불량하다[3,7].”
InfluentialFazio, N. (2005) · Therapy · doi:10.2217/14750708.2.2.229
“In rare cases an atypical carcinoid syndrome can be present [3], but in most cases GI NETs are non-functioning.”
BackgroundDuodeno-pancreatic neuroendocrine tumours
Peros, G., Sakorafas, G. H., Konstantoudakis, G., Γιαννόπουλος, Γ., Petropoulou, K. B., & Parasi, A. S. (2009) · European Journal of Cancer Care · doi:10.1111/j.1365-2354.2007.00894.x
Valatsou, A., & Tzanela, M. (2011) · Hellenic Journal of Surgery · doi:10.1007/s13126-011-0004-7
“Surgery remains the treatment of choice and the only approach that can achieve cure in patients with NETs [1, 2 ].”
BackgroundInfluentialHe, S., Yan, Q., Chen, X., Zhang, J., Lu, X., Pan, H., & Chen, L. (2007) · Chinese Journal of Clinical Oncology · doi:10.1007/s11805-007-0416-x
“At present the biologic tumor features are used as a basis for determining the post-operative survival of the patients with a NE tumor [ 5 ] . Extensive research is being conducted on NE cells of GC by studying the relationship between NE cells and GC malignancy to improve prognosis of GC cases.”
BackgroundChirurgische Therapie neuroendokriner Lebermetastasen – Resektion, Transplantation
Frilling, A., Sotiropoulos, G. C., Kornasiewicz, O., Tedeschi, M., & Li, J. (2010) · Viszeralmedizin · doi:10.1159/000322553
Trasplante hepático en tumor carcinoide de páncreas metastático
González-Molero, I., López, M. E. D., Plaza, C. P. R., & Santoyo, J. S. (2010) · Medicina Clínica · doi:10.1016/j.medcli.2010.04.025
Mass, F. J. T., Verd, I. L., Estall, I. B., Cascales, A. B. H., Lpez, M. F., & Ortega, P. P. (2008) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/s0211-3449(08)73103-5
Somatostatinoma of the Pancreas; Difficulties in Preoperative Diagnostic Approaches — A Case Report
Dranka-Bojarowska, D., Olakowski, M., & Lampe, P. (2007) · Polish Journal of Surgery · doi:10.2478/v10035-007-0021-y
Chatti, K., Guezguez, M., Chhoumi, M., Sfar, R., Nouira, M., Fredj, M. B., & ESSABBAH, H. (2009) · Médecine Nucléaire · doi:10.1016/j.mednuc.2009.07.010
Biffi, R., Orsi, S., Zampino, M., Chiappa, A., Fazio, N., Braud, F. D., Bonomo, G., Monfardini, L., Vigna, P. D., Luca, F., et al. (2008) · ecancermedicalscience · doi:10.3332/ecancer.2008.64
Midgut Carcinoid Tumor in an Elderly Female: A Rare Case Report
Shanker, M., Avadhani, G., Edwine, V., Arun, K., & Prajwal, S. (2015)
Cytology of medullary thyroid carcinoma – report of 4 cases
Ambawade Vibhuti, D., Gawai Amita, R., Gupta, A., & Kate, M. S. (2013) · DOAJ (DOAJ: Directory of Open Access Journals)
Benkirane, O., Ouazzani, L., Mernissi, H. E., Errabih, I., Benzzoubeir, N., Krami, H., Hroura, A., Jahid, A., Kettani, F., & Ouazzani, H. E. (2010) · Journal Africain d Hépato-Gastroentérologie · doi:10.1007/s12157-010-0178-6
Carcinoid Syndrome Corresponding Author
Tirunagari, S. (2013)
Neuroendocrine tumours of rare location Guzy neuroendokrynne o rzadkiej lokalizacji
Hubalewska–Dydejczyk, A., Sowa‐Staszczak, A., Gilis‐Januszewska, A., Anielski, R., & Kunikowska, J. (2010)
원저 : 위장관 유암종의 내시경적 치료 성적에 대한 고찰
박용범, 김진일, 하병화, 정대영, 김태호, 김창환, 김성수, 조세현, 박수헌, 채현석, et al. (2007) · The Korean Journal of Internal Medicine
Metastatic Glucagonoma Presenting with Weight Loss and Necrolytic Migratory Erythema
Mallonga, M. K., Calimon, M. A., Labitag, A. R., & Villa, M. (2015) · Journal of the ASEAN Federation of Endocrine Societies · doi:10.15605/jafes.030.02.13
Polyps of the Colon and Rectum
Garber, J. J., & Chung, D. C. (2015) · Wiley eBooks · doi:10.1002/9781118512074.ch77
Mindang, P. N., Haumont, S., & Plat, L. (2013) · Annales d Endocrinologie · doi:10.1016/j.ando.2013.07.500
Principaux marqueurs circulantsutilisables en cancérologie
You, B. (2007) · Oncomagazine · doi:10.1007/bf03165459
Marqueurs tumoraux et cancers du tractus gastro-intestinal
Samalin, E., & Ychou, M. (2009) · EMC - Gastro-entérologie · doi:10.1016/s1155-1968(09)49514-2
Abras, N., Mehinto, D., & Mathonnet, M. (2012)
Феохромоцитома с эктопической продукцией АКТГ: разбор клинических случаев
Marova, E. I., Voronkova, I. А., Лапшина, А. М., Arapova, S., S, K. N., Ya, R. L., Животов, В. А., Gurevich, L. E., Polyakova, G. A., & Полякова, Г. А. (2015) · Cited by 1
Camara, R. (2016) · University of Hertfordshire Research Archive (University of Hertfordshire) · doi:10.18745/th.17117
“endocrine tumours are poorly understood, it is believed that genes that are mainly associated with exocrine pancreatic cancer are not involved in pancreatic endocrine tumours [78].”
BackgroundCarcinoma neuroendocrino del intestino delgado Gastrintestinal neuroendocrine carcinoma. Case report
González, G. G., Arias, P. T. A., Vásquez, C. J., Melo, L. J. R., Botero, O. A. M., Neira, E. E. F., Grimaldo, G. A. H., & Llamas, E. O. A. (2008)
ЦИТОКИНОВЫЕ МЕХАНИЗМЫ ДЕГЕНЕРАЦИИ МЕЖПОЗВОНКОВОГО ДИСКА
Анатольевич, Б. В., Георгиевич, Б. Е., Андреевич, С. И., Морган, Г., & Prul, M. (2015) · Сибирский медицинский журнал (Иркутск) · doi:10.1234/xxxx-xxxx-2015-6-5-11
Grimaldi, F., Fazio, N., Attanasio, R., Frasoldati, A., Zini, M., Nuova, S. M., Papini, E., Angelini, F., Bianchetti, S., Baldelli, R., et al. (2014)
Chayvialle, J. A., & Lombard‐Bohas, C. (2008) · Oncomagazine · doi:10.1007/bf03165477
Gorshtein, A., Strenov, Y., Mor, E., Shimon, I., & Grozinsky‐Glasberg, S. (2011) · PubMed
Manifestations neuro-ophtalmologiques révélatrices d’un carcinome neuroendocrine du sinus
Ouederni, M., Dhouib, N., Brour, J., Romdhane, B. B., Mekni, M., & Cheour, M. (2016) · Journal Français d Ophtalmologie · doi:10.1016/j.jfo.2015.11.013
Two cases of thyroid small cell carcinoma
Sim, S. H., Kim, H. J., Kim, M., Cha, Y., Lee, Y. S., Lim, K., & Lee, S. (2009) · The Korean Journal of Internal Medicine
Patrón dermoscópico en arcoíris y rosetas en cicatrices cutáneas
Arrue, I., Catón, B., & Soloeta, R. (2016)
Octreotide therapy in a patient with lung microcytoma
Adua, D., Gori, B., Stumbo, L., Signore, E. D., & Longo, F. (2015) · Clinical Management Issues · doi:10.7175/cmi.v4i1s.1064
Clinical Approaches to the Management of Neuroendocrine Tumours
Yim, K.-L., Thomas, B. M., & Christian, A. D. (2015) · Springer eBooks · doi:10.1007/978-3-319-21683-6_32
The Role of mTOR Inhibitors in Neuroendocrine Tumors
Hendifar, A. E., Liu, S. T., & Wolin, E. M. (2015) · Springer eBooks · doi:10.1007/978-2-8178-0492-7_5
Nuclear Medicine as an Aid to Minimally Invasive Surgery, with Emphasis on Hybrid SPECT/CT Imaging
Orsini, F., Serra, A., Piga, M., & Mariani, G. (2014) · CRC Press eBooks · doi:10.1201/b17799-40
Molecular Pathology of Neuroendocrine Tumor: The Era of Targeted Therapeutics
Magliocco, A. M. (2016) · Springer eBooks · doi:10.1007/978-1-4939-3426-3_23
Emerging treatment modalities for advanced pancreatic neuroendocrine tumors
Sindoni, A., Famà, F., Gioffré‐Florio, M., & Baldari, S. (2016) · HORMONES · doi:10.14310/horm.2002.1702
Domingos, V., Rosa, L., Carlos, A. D. S. J., Godoy, C., Thomé, J. L. C., Rapatoni, L., Saggioro, F. P., Neder, L., de Oliveira, R. C., de Oliveira, H. F., et al. (2015)
Molecular Genetics of Gastroenteropancreatic Neuroendocrine Tumours
Backman, S., & Björklund, P. (2016) · Springer eBooks · doi:10.1007/978-3-319-46038-3_6
Radionuclide Imaging of Gastrointestinal Neuroendocrine Tumors
Impériale, A., Deroose, C. M., Hindié, E., & Goichot, B. (2016) · Springer eBooks · doi:10.1007/978-3-319-46038-3_15
Malignant insulinoma presenting with portal venous thrombosis and variceal bleeding
Sahu, P., Mishra, S., Kathuria, P., Kumar, S., & Kar, P. (2016) · Tropical Gastroenterology · doi:10.7869/tg.383
“302 Tropical Gastroenterology 2016;37(4):302-304”
Management of Ileal, Appendiceal and Colorectal Neuroendocrine Tumors
Carlini, M., Spoletini, D., Grieco, M., Apa, D., Appetecchia, M., Lauretta, R., Palazzo, S., Minardi, S., Severi, S., & lanniello, A. (2017) · Updates in surgery/Updates in surgery series · doi:10.1007/978-88-470-3955-1_12
Problemi andrologici nell'uomo obeso
Lombardo, F., Corona, G., Maggi, M., & Moghetti, P. (2012)
Tadman, M., Charlton, P. V., Jafar‐Mohammadi, B., Talbot, D. C., & Grossman, A. B. (2018) · Endocrine Practice · doi:10.4158/ep-2017-0137
Self-citationEpidemiology and Classification of Neuroendocrine Tumors of the Pancreas
Mukherjee, J. J., Lee, K., & Kaltsas, G. (2018) · Wiley eBooks · doi:10.1002/9781119188421.ch121
Self-citationCirculating Markers in Neuroendocrine Tumors
Seregni, E. C., & Lorenzoni, A. (2018) · Springer eBooks · doi:10.1007/978-3-319-62506-5_15 · Cited by 1
Acute Endocrine and Metabolic Emergencies Related to Neuroendocrine Tumors
Kaltsas, G., Alexandraki, K., & Grossman, A. B. (2018) · Wiley eBooks · doi:10.1002/9781119374800.ch29
Self-citationEffekte der Therapie mit Somatostatin-Analoga bei neuroendokrinen Tumoren
Bresch, L. M. (2016) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-5742
VIPoma, Glucagonoma, and Somatostatinoma
Zandee, W. T., & de Herder, W. W. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64340-4
Metadata
- Authors
- Kaltsas, G. A., Besser, G. M., & Grossman, A. B.
- Affiliations
- St Bartholomew's Hospital (GB)
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2004-06-01
- Volume
- 25
- Issue
- 3
- Pages
- 458-511
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2031301095
- Semantic Scholar
- b09a37699a89446c4662f1bc87eb975bf31118b7
- Cited by
- 674
- References
- 670
- Citations by year
- 2026: 4 · 2025: 19 · 2024: 17 · 2023: 26 · 2022: 17 · 2021: 23 · 2020: 23 · 2019: 24 · 2018: 31 · 2017: 27 · 2016: 34 · 2015: 46 · 2014: 30 · 2013: 37 · 2012: 49
- FWCI
- 4.65
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrine Reviews (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Neuroendocrine Tumor Research Advances
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
- Keywords
- neuroendocrine tumors, diagnosis, tumor markers, endocrine syndromes, somatostatin analogues, MIBG scintigraphy, endoscopic ultrasound, interferon-alpha, chemotherapy, radionuclide therapy, multimodal therapy, quality of life
- MeSH terms
- Adrenal Gland Neoplasms, Animals, Antineoplastic Combined Chemotherapy Protocols, Gastrointestinal Neoplasms, Humans, Pancreatic Neoplasms, Parathyroid Neoplasms, Pituitary Neoplasms, Prognosis, Quality of Life, Sensitivity and Specificity, Somatostatin, Thyroid Neoplasms, Tomography, X-Ray Computed, Biomarkers, Tumor, Interferon-alpha, Carcinoma, Neuroendocrine, Neuroendocrine Tumors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.